Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
N4BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UBXN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928595 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM106A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR3C2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM83A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRAK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLA2G4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYNRG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAPP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
QKI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEGF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHOC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on